NAD+ homeostasis in health and disease
- PMID: 32694684
- DOI: 10.1038/s42255-019-0161-5
NAD+ homeostasis in health and disease
Abstract
The conceptual evolution of nicotinamide adenine dinucleotide (NAD+) from being seen as a simple metabolic cofactor to a pivotal cosubstrate for proteins regulating metabolism and longevity, including the sirtuin family of protein deacylases, has led to a new wave of scientific interest in NAD+. NAD+ levels decline during ageing, and alterations in NAD+ homeostasis can be found in virtually all age-related diseases, including neurodegeneration, diabetes and cancer. In preclinical settings, various strategies to increase NAD+ levels have shown beneficial effects, thus starting a competitive race to discover marketable NAD+ boosters to improve healthspan and lifespan. Here, we review the basics of NAD+ biochemistry and metabolism, and its roles in health and disease, and we discuss current challenges and the future translational potential of NAD+ research.
Similar articles
-
Modulating NAD+ metabolism, from bench to bedside.EMBO J. 2017 Sep 15;36(18):2670-2683. doi: 10.15252/embj.201797135. Epub 2017 Aug 7. EMBO J. 2017. PMID: 28784597 Free PMC article. Review.
-
Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.Biochem Soc Trans. 2020 Jun 30;48(3):733-744. doi: 10.1042/BST20190033. Biochem Soc Trans. 2020. PMID: 32573651 Review.
-
Metabolic control by sirtuins and other enzymes that sense NAD+, NADH, or their ratio.Biochim Biophys Acta Bioenerg. 2017 Dec;1858(12):991-998. doi: 10.1016/j.bbabio.2017.09.005. Epub 2017 Sep 22. Biochim Biophys Acta Bioenerg. 2017. PMID: 28947253 Free PMC article. Review.
-
Pyridine Dinucleotides from Molecules to Man.Antioxid Redox Signal. 2018 Jan 20;28(3):180-212. doi: 10.1089/ars.2017.7120. Epub 2017 Jul 25. Antioxid Redox Signal. 2018. PMID: 28635300 Free PMC article. Review.
-
NAD⁺ metabolism: a therapeutic target for age-related metabolic disease.Crit Rev Biochem Mol Biol. 2013 Jul-Aug;48(4):397-408. doi: 10.3109/10409238.2013.789479. Epub 2013 Jun 6. Crit Rev Biochem Mol Biol. 2013. PMID: 23742622 Free PMC article. Review.
Cited by
-
Potential Therapeutic Interventions Targeting NAD+ Metabolism for ALS.Cells. 2024 Sep 9;13(17):1509. doi: 10.3390/cells13171509. Cells. 2024. PMID: 39273079 Free PMC article. Review.
-
NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review.Nutrients. 2024 Aug 21;16(16):2795. doi: 10.3390/nu16162795. Nutrients. 2024. PMID: 39203931 Free PMC article. Review.
-
Nicotinamide: Bright Potential in Glaucoma Management.Biomedicines. 2024 Jul 25;12(8):1655. doi: 10.3390/biomedicines12081655. Biomedicines. 2024. PMID: 39200120 Free PMC article. Review.
-
A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models.Antioxidants (Basel). 2024 Aug 22;13(8):1023. doi: 10.3390/antiox13081023. Antioxidants (Basel). 2024. PMID: 39199267 Free PMC article.
-
Metabolite signaling in the heart.Nat Cardiovasc Res. 2023 Jun;2(6):504-516. doi: 10.1038/s44161-023-00270-6. Epub 2023 May 25. Nat Cardiovasc Res. 2023. PMID: 39195876 Review.
References
-
- Harden, A. & Young, W. The alcoholic ferment of yeast‐juice. Proc. R. Soc. Lond. B 77, 405–420 (1906). - DOI
-
- von Euler, H. & Myrbäck, K. Co‐zymase. XVII. Hoppe-Seyler’s Z. Physiol. Chem. 190, 93–100 (1930). - DOI
-
- Warburg, O. & Christian, W. Pyridine, the hydrogen transfusing component of fermentative enzymes. Helv. Chim. Acta 19, 79–88 (1936). - DOI
-
- Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000). - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources